Wakefield Asset Management's Q4 2022 13F Filing: Top Changes in Holdings Analysis

Wakefield Asset Management LLLP is a diversified investment management firm that employs an active investment management style to develop investment strategies that help its clients achieve their financial objectives. The firm was established in 2008 and has its headquarters in New York City.

Wakefield Asset Management recently released its 13F filing for Q3 2022 and Q4 2022, detailing its holdings in various securities. The filing showed that the firm made some significant changes to its portfolio during the quarter, including adding to some positions and reducing others.

The following is an analysis of the top changes in holdings by Wakefield Asset Management during the quarter, based on the data from the 13F filing.

IEMG

Wakefield Asset Management reduced its holdings in the iShares Inc Emerging Markets ETF (IEMG) by 26.2% during the quarter, going from 153,257 shares in Q3 2022 to 104,141 shares in Q4 2022. The value of the holdings in IEMG decreased from $6,587,000 to $4,863,000.

The iShares Inc Emerging Markets ETF is designed to provide exposure to stocks in emerging market countries. The fund seeks to track the investment results of an index composed of large- and mid-capitalization emerging market equities.

WIW

Wakefield Asset Management added to its holdings in the Western Ast Infl Lkd Opp & I (WIW) during the quarter, going from 257,963 shares in Q3 2022 to 398,843 shares in Q4 2022, a 55.6% increase. The value of the holdings in WIW increased from $2,340,000 to $3,641,000.

The Western Ast Infl Lkd Opp & I is a closed-end fund that seeks to provide income and capital appreciation by investing in a combination of inflation-indexed securities and inflation-related derivative instruments.

GILD

Wakefield Asset Management increased its holdings in Gilead Sciences Inc (GILD) during the quarter, going from 5,269 shares in Q3 2022 to 34,368 shares in Q4 2022, an increase of 607.7%. The value of the holdings in GILD increased from $325,000 to $2,950,000.

Gilead Sciences is a biopharmaceutical company that develops and commercializes therapeutics for the treatment of human immunodeficiency virus (HIV), liver diseases, and other viral infections.

URI

Wakefield Asset Management added to its holdings in United Rentals Inc (URI) during the quarter, going from 7,875 shares in Q3 2022 to 7,844 shares in Q4 2022, a 31.1% increase. The value of the holdings in URI increased from $2,127,000 to $2,787,000.

United Rentals is a company that provides equipment rental services to customers in the construction, industrial, and commercial markets.

PFXF

Wakefield Asset Management added a new position in the VanEck ETF Trust (PFXF) during the quarter, going from 0 shares in Q3 2022 to 176,854 shares in Q4 2022. The value of the holdings in PFXF was $2,955,000.

The VanEck ETF Trust is an exchange-traded fund that seeks to track the performance of the Preferred Securities ex Financials Index.

ROST

Wakefield Asset Management added a new position in Ross Stores Inc (ROST) during the quarter, going from 0 shares in Q3 2022 to 22,364 shares in Q4 2022. The value of the holdings in ROST was $2,595,000.

Ross Stores is a company that operates off-price retail apparel and home fashion stores.

Conclusion

Wakefield Asset Management made some strategic changes to its portfolio during the quarter. While the firm reduced its position in IEMG, it added to its holdings in WIW, GILD, URI, PFXF, and ROST. These changes show that the firm is engaged in active investment management, seeking to allocate its resources based on its assessment of market conditions and investment opportunities.

It is important to note that while the 13F filing provides useful information about Wakefield Asset Management's holdings, it is not a comprehensive or real-time representation of the firm's activities. The filing provides a snapshot of the firm's holdings at the end of the quarter and does not necessarily reflect its current or future positions. As such, investors should exercise caution when using this information to make investment decisions.